BACKGROUND: Recent studies suggest that cytokines modulate bone turnover. Idiopathic hypercalciuria (IH) seems to be associated with bone mineral loss. Therefore, the aim of this study was to assess cytokines involved in bone turnover in patients with IH. METHODS: Plasma and spot-urine levels of interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor alpha (TNF-α), transforming growth factor β1 (TGF-β1), and monocyte chemoattractant protein (MCP-1) were measured in 70 children and adolescents with IH and in 37 healthy controls. Patients with IH were subdivided according to their calciuria at the time of sample collection: ≥4 mg/kg/day (persistent IH, n=27) and below 4 mg/kg/day (controlled IH, n=43). Cytokines were determined by enzyme-linked immunoassay. RESULTS: Plasma and urinary concentrations of IL-1β, IL-6, IL-8, and TNF-α were undetectable in all groups. No differences were found between controlled and persistent hypercalciuria for plasma and urinary levels of MCP-1 and TGF-β1. On the other hand, MCP-1 levels were significantly higher in both subgroups of IH in comparison to healthy controls. Furthermore, urinary MCP-1 levels of IH patients correlated positively with bone mineral content (p=0.013). CONCLUSION: Although cytokine measurements did not allow the differentiation between persistent and controlled IH, our findings suggest that MCP-1 might play a role in patients with IH.
BACKGROUND: Recent studies suggest that cytokines modulate bone turnover. Idiopathic hypercalciuria (IH) seems to be associated with bone mineral loss. Therefore, the aim of this study was to assess cytokines involved in bone turnover in patients with IH. METHODS: Plasma and spot-urine levels of interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor alpha (TNF-α), transforming growth factor β1 (TGF-β1), and monocyte chemoattractant protein (MCP-1) were measured in 70 children and adolescents with IH and in 37 healthy controls. Patients with IH were subdivided according to their calciuria at the time of sample collection: ≥4 mg/kg/day (persistent IH, n=27) and below 4 mg/kg/day (controlled IH, n=43). Cytokines were determined by enzyme-linked immunoassay. RESULTS: Plasma and urinary concentrations of IL-1β, IL-6, IL-8, and TNF-α were undetectable in all groups. No differences were found between controlled and persistent hypercalciuria for plasma and urinary levels of MCP-1 and TGF-β1. On the other hand, MCP-1 levels were significantly higher in both subgroups of IH in comparison to healthy controls. Furthermore, urinary MCP-1 levels of IH patients correlated positively with bone mineral content (p=0.013). CONCLUSION: Although cytokine measurements did not allow the differentiation between persistent and controlled IH, our findings suggest that MCP-1 might play a role in patients with IH.
Authors: Augusto C S Santos; Eleonora M Lima; Eduardo Araújo Oliveira; Ana Cristina Simões e Silva Journal: J Pediatr Endocrinol Metab Date: 2011 Impact factor: 1.634
Authors: A Ghazali; V Fuentès; C Desaint; P Bataille; A Westeel; M Brazier; L Prin; A Fournier Journal: J Clin Endocrinol Metab Date: 1997-01 Impact factor: 5.958
Authors: A M Misael da Silva; L M dos Reis; R C Pereira; E Futata; C T Branco-Martins; I L Noronha; B L Wajchemberg; V Jorgetti Journal: Clin Nephrol Date: 2002-03 Impact factor: 0.975
Authors: J M Quinn; K Itoh; N Udagawa; K Hausler; H Yasuda; N Shima; A Mizuno; K Higashio; N Takahashi; T Suda; T J Martin; M T Gillespie Journal: J Bone Miner Res Date: 2001-10 Impact factor: 6.741
Authors: Marcelo F O Souto; Antônio L Teixeira; Remo C Russo; Maria-Goretti M G Penido; Kátia D Silveira; Mauro M Teixeira; Ana C Simões E Silva Journal: Pediatr Res Date: 2008-12 Impact factor: 3.756
Authors: Ellen R Brooks; Bernd Hoppe; Dawn S Milliner; Eduardo Salido; John Rim; Leah M Krevitt; Julie B Olson; Heather E Price; Gulsah Vural; Craig B Langman Journal: Am J Nephrol Date: 2016-05-03 Impact factor: 3.754